5 : The Global Epidemiology of AIDS

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Ebook: Choose a downloadable PDF or ePub file. Chapter is a downloadable PDF file. File must be downloaded within 48 hours of purchase

Buy this Chapter
Digital (?) $15.00

Preview this chapter:
Zoom in

The Global Epidemiology of AIDS, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555816995/9781555812423_Chap05-1.gif /docserver/preview/fulltext/10.1128/9781555816995/9781555812423_Chap05-2.gif


In 1981, the first cases of AIDS were recognized in previously healthy homosexual men residing in the United States. Within just a few years, thousands of cases were recognized in members of other high-risk groups, including injecting drug users (IDUs), hemophiliacs, and recipients of blood transfusions. The diversity of the global AIDS pandemic is also reflected in the heterogeneity of the viral subtypes of HIV. Recent studies have suggested that HIV entered the human population through multiple zoonotic infections from simian immunodeficiency virus (SIV)-infected nonhuman primates sometime in the early to mid-20th century. In 1985, a second human retrovirus associated with AIDS, HIV-2, was identified in West Africa. This virus has been found to have relatively high prevalence rates among hospitalized patients, female prostitutes, and patients who attend sexually transmitted disease (STD) clinics in several countries of West Africa. Sub-Saharan Africa represents the epicenter of the global HIV/AIDS pandemic. HIV/AIDS is now the leading cause of death in some countries of the Caribbean basin.

Citation: Quinn T. 2004. The Global Epidemiology of AIDS, p 59-82. In Scheld W, Murray B, Hughes J (ed), Emerging Infections 6. ASM Press, Washington, DC. doi: 10.1128/9781555816995.ch5
Highlighted Text: Show | Hide
Loading full text...

Full text loading...


Image of Figure 1
Figure 1

Historical perspective on the timeline of HIV/AIDS as shown by the epidemic increase in the number of people living with HIV/AIDS worldwide. (source: reference .)

Citation: Quinn T. 2004. The Global Epidemiology of AIDS, p 59-82. In Scheld W, Murray B, Hughes J (ed), Emerging Infections 6. ASM Press, Washington, DC. doi: 10.1128/9781555816995.ch5
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 2
Figure 2

According to UNAIDS estimates, 42 million adults and children were living with HIV/AIDS in 2002. Distribution of infected people is shown by region. (source: reference .)

Citation: Quinn T. 2004. The Global Epidemiology of AIDS, p 59-82. In Scheld W, Murray B, Hughes J (ed), Emerging Infections 6. ASM Press, Washington, DC. doi: 10.1128/9781555816995.ch5
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 3
Figure 3

Distribution of HIV/AIDS deaths in 2001 and the number of people using antiretroviral drugs during the same time period by region. Note the extraordinarily large number of deaths in sub-Saharan Africa in contrast to the small number of people using antiretroviral drugs. Data from UNAIDS ( ).

Citation: Quinn T. 2004. The Global Epidemiology of AIDS, p 59-82. In Scheld W, Murray B, Hughes J (ed), Emerging Infections 6. ASM Press, Washington, DC. doi: 10.1128/9781555816995.ch5
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 4
Figure 4

Reduction in life expectancy compared to the “no AIDS” scenario in selected countries, 2000 to 2005. (source: reference .)

Citation: Quinn T. 2004. The Global Epidemiology of AIDS, p 59-82. In Scheld W, Murray B, Hughes J (ed), Emerging Infections 6. ASM Press, Washington, DC. doi: 10.1128/9781555816995.ch5
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 5
Figure 5

Cumulative reported HIV infections per million population in eastern European countries, 1993 to 2001. Data from UNAIDS ( ).

Citation: Quinn T. 2004. The Global Epidemiology of AIDS, p 59-82. In Scheld W, Murray B, Hughes J (ed), Emerging Infections 6. ASM Press, Washington, DC. doi: 10.1128/9781555816995.ch5
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 6
Figure 6

Estimated AIDS incidence, deaths, and prevalence by quarter year of diagnosis or death for the United States, 1981–2000. Data from the Centers for Disease Control and Prevention ( ).

Citation: Quinn T. 2004. The Global Epidemiology of AIDS, p 59-82. In Scheld W, Murray B, Hughes J (ed), Emerging Infections 6. ASM Press, Washington, DC. doi: 10.1128/9781555816995.ch5
Permissions and Reprints Request Permissions
Download as Powerpoint


1. Adjorlolo-Johnson, G.,, K. M. De Cock,, E. Ekpini,, K. M. Vetter,, T. Sibailly,, K. Brattegaard,, D. Yavo,, R. Doorly,, J. P. Whitaker,, and L. Kestens. 1994. Prospective comparison of mother-to-child transmission of HIV-1 and HIV-2 in Abidjan, Ivory Coast. JAMA 272:462466.
2. Agwale, S. M.,, C. Zeh, K. E. Robbins,, L. Odama,, A. Saekhou,, A. Edubio,, M. Njoku,, N. Sani-Gwarzo,, M. S. Gboun,, F. Gao,, M. Reitz,, D. Hone,, D. Pieniazek,, C. Wambebe,, and M. L. Kalish. 2002. Molecular surveillance of HIV-1 field strains in Nigeria in preparation for vaccine trials. Vaccine 20:21312139.
3. Alaeus, A. 2000. Significance of HIV-1 genetic subtypes. Scand. J. Infect. Dis. 32:455463.
4. Barre-Sinoussi, F.,, J. C. Chermann,, F. Rey,, C. Axler-Blin,, F. Vezinet-Brun,, C. Rouzioux,, W. Rozenbaum,, and L. Montagnier. 1983. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 220:868871.
5. Blair, J. M.,, P. L. Fleming,, and J. M. Karon. 2002. Trends in AIDS incidence and survival among racial/ethnic minority men who have sex with men, United States, 1990–1999. J. Acquir. Immune Defic. Syndr. 31:339347.
6. Bollinger, R. C.,, S. P. Tripathy,, and T. C. Quinn. 1995. The human immunodeficiency virus epidemic in India. Medicine (Baltimore) 74:97106.
7. Brown, T.,, and W. Sittirai. 1995. The HIV/AIDS epidemic in Thailand: addressing the impact on children. In Asia-Pacific Population and Policy, No. 35. Honolulu, HI: East-West Center Program on Population.
8. Brown, T.,, W. Sittirai,, S. Vanichseni,, and U. Thisyakom. 1994. The recent epidemiology of HIV and AIDS in Thailand. AIDS 8(Suppl. 2):S131S141.
9. Buve, A.,, K. Bishikwabo-Nsarhaza,, and G. Mutangadura. 2002. The spread and effect of HIV-1 infection in sub-Saharan Africa. Lancet 359:20112017.
10. Calleja, J. M.,, N. Walker,, P. Cuchi,, S. Lazzari,, P. D. Ghys,, and F. Zacarias. 2002. Status of the HIV/AIDS epidemic and methods to monitor it in the Latin America and Caribbean region. AIDS 16(Suppl. 3):S3S12.
11. Centers for Disease Control. 1983. Acquired immunodeficiency syndrome (AIDS) update—United States. Morb. Mortal. Wkly. Rep. 32:309.
12. Centers for Disease Control. 1981. Kaposi's sarcoma and Pneumocystis pneumonia among homosexual men—New York City and California. Morb. Mortal. Wkly. Rep. 30:305.
13. Centers for Disease Control and Prevention. 2001. HIV and AIDS—United States, 1981–2000. Morb. Mortal. Wkly. Rep. 50:430434.
14. Centers for Disease Control and Prevention. 2003. Advancing HIV prevention: new strategies for a changing epidemic—United States, 2003. Morb. Mortal. Wkly. Rep. 52:329332.
15. Centers for Disease Control and Prevention. 2001. HIV incidence among young men who have sex with men—seven U.S. cities, 1994–2000. Morb. Mortal. Wkly. Rep. 50:441444.
16. Centers for Disease Control and Prevention. 2001. HIV testing among racial/ethnic minorities—United States, 1999. Morb. Mortal. Wkly. Rep. 50:10541058.
17. Centers for Disease Control and Prevention. 2001. The global HIV and AIDS epidemic, 2001. Morb. Mortal. Wkly. Rep. 50:434439.
18. Centers for Disease Control and Prevention. 2002. Update: AIDS—United States, 2000. Morb. Mortal. Wkly. Rep. 51:592595.
19. Chen, J.,, N. L. Young,, S. Subbarao,, P. Warachit,, S. Saguanwongse,, S. Wongsheree,, C. Jayavasu,, C. C. Luo,, and T. D. Mastro. 1999. HIV type 1 subtypes in Guangxi Province, China, 1996. AIDS Res. Hum. Retrovir. 15:8184.
20. Cheng, H.,, J. Zhang,, J. Capizzi,, and D. Mastro. 1994. Introduction of HIV-1 subtype E into Yunnan, China. Lancet 344:953954.
21. Clavel, F. 1987. HIV-2, the West African AIDS virus. AIDS 1:135140.
22. Clavel, F.,, D. Guetard,, F. Brun-Vezinet,, D. Guetard,, F. Brun-Vezinet,, S. Chamaret,, M. A. Rey,, M. O. Santos-Ferreira,, A. G. Laurent,, C. Dauguet,, C. Katlama,, and C. Rouzioux. 1986. Isolation of a new retrovirus from West African patients with AIDS. Science 233:343346.
23. Clavel, F.,, K. Mansinho,, S. Chamaret,, D. Guetard,, V. Favier,, J. Nina,, M. O. Santos-Ferreira,, J. L. Champalimaud,, and L. Montagnier. 1987. Human immunodeficiency virus type 2 infection associated with AIDS in West Africa. N. Engl. J. Med. 316:11801185.
24. Clinton, W. J. 2003. Turning the tide on the AIDS pandemic. N. Engl. J. Med. 348:18001801.
25. Connor, E. M.,, R. S. Sperling,, R. Gelber,, P. Kiselev,, G. Scott,, M. J. O'Sullivan,, R. VanDyke,, M. Bey,, W. Shearer,, and R. L. Jacobson. 1994. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N. Engl. J. Med. 331:11731180.
26. Cornelissen, M.,, R. van den Burg,, F. Zorgdrager,, and J. Goudsmit. 2000. Spread of distinct human immunodeficiency virus type 1 AG recombinant lineages in Africa. J. Gen. Virol. 81(Pt. 2):515523.
27. De Cock, K. M.,, G. Adjorlolo,, E. Ekpini,, T. Sibailly,, J. Kouadio,, M. Maran,, K. Brattegaard,, K. M. Vetter,, R. Doorly,, and H. D. Gayle. 1993. Epidemiology and transmission of HIV-2. Why there is no HIV-2 pandemic. JAMA 270:20832086.
28. De Cock, K. M.,, B. Barrere,, L. Diaby,, M. F. Fontaine,, E. Gnanore,, A. Porter,, D. Pantobe,, G. C. Lafontant,, A. Dago-Akribi,, and M. Ette. 1990. AIDS—the leading cause of adult death in the west African city of Abidjan, Ivory Coast. Science 249:793796.
29. De Cock, K. M.,, and F. Brun-Vezinet. 1989. Epidemiology of HIV-2 infection. AIDS 3(Suppl. 1):S89S95.
30. De Cock, K. M.,, D. Mbori-Ngacha,, and E. Marum. 2002. Shadow on the continent: public health and HIV/AIDS in Africa in the 21st century. Lancet 360:6772.
31. De Cock, K. M.,, B. Soro,, I.-M. Coulibaly,, and S. B. Lucas. 1992. Tuberculosis and HIV infection in sub- Saharan Africa. JAMA 268:15811587.
32. Decosas, J.,, F. Kane,, J. K. Anarfi,, K. D. Sodji,, and H. U. Wagner. 1995. Migration and AIDS. Lancet 346:826828.
33. Dondero, T. J.,, and J. W. Curran. 1995. Excess deaths in Africa from HIV: confirmed and quantified. Lancet 343:989990.
34. Fleming, D. T.,, and J. N. Wasserheit. 1999. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex. Transm. Infect. 75:317.
35. Fox, K. K.,, C. del Rio,, K. K. Holmes,, E. W. Hook III,, F. N. Judson,, J. S. Knapp,, G. W. Procop,, S. A. Wang,, W. L. Whittington,, and W. C. Levine. 2001. Gonorrhea in the HIV era: a reversal in trends among men who have sex with men. Am. J. Public Health 91:959964.
36. Gallo, R. C.,, S. Z. Salahuddin,, M. Popovic,, G. M. Shearer,, M. Kaplan,, B. F. Haynes,, T. J. Palker,, R. Redfield,, J. Oleske,, and B. Safai. 1984. Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science 224:500503.
37. Gao, F.,, E. Bailes,, D. L. Robertson,, Y. Chen,, C. M. Rodenburg,, S. F. Michael,, L. B. Cummings,, L. O. Arthur,, M. Peeters,, G. M. Shaw,, P. M. Sharp,, and B. H. Hahn. 1999. Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes. Nature 397:436441.
38. Gaschen, B.,, J. Taylor,, K. Yusim,, B. Foley,, F. Gao,, D. Lang,, V. Novitsky,, B. Haynes,, B. H. Hahn,, T. Bhattacharya,, and B. Korber. 2002. Diversity considerations in HIV-1 vaccine selection. Science 296:23542360.
39. Gayle, H. D. 2003. Curbing the global AIDS epidemic. N. Engl. J. Med. 348:18021803.
40. Gayle, H. D.,, and G. L. Hill. 2001. Global impact of human immunodeficiency virus and AIDS. Clin. Microbiol. Rev. 14:327335.
41. Goedert, J. J.,, M. E. Eyster,, R. J. Bigger,, and W. A. Blattner. 1987. Heterosexual transmission of human immunodeficiency virus: association with severe depletion of T-helper lymphocytes in men with hemophilia. AIDS Res. Hum. Retrovir. 4:355366.
42. Gottlieb, M. S.,, R. Schroff,, H. M. Schanker,, J. D. Weisman,, P. T. Fan,, R. A. Wolf,, and A. Saxon. 1981. Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency. N. Engl. J. Med. 305:14251431.
43. Gray, R. H.,, N. Kiwanuka,, T. C. Quinn,, N. K. Sewankambo,, D. Serwadda,, F. W. Mangen,, T. Lutalo,, F. Nalugoda,, R. Kelly,, M. Meehan,, M. Z. Chen,, C. Li,, and M. J. Wawer. 2000. Male circumcision and HIV acquisition and transmission: cohort studies in Rakai, Uganda. Rakai Project Team. AIDS 14:23712381.
44. Hahn, B. H.,, G. M. Shaw,, K. M. De Cock,, and P. M. Sharp. 2000. AIDS as a zoonosis: scientific and public health implications. Science 287:607614.
45. Hamers, F. F.,, and A. M. Downs. 2003. HIV in central and eastern Europe. Lancet 361:10351044.
46. Harries, A. D. 1990. Tuberculosis and human immunodeficiency virus infection in developing countries. Lancet 335:387390.
47. Kaldor, J. M.,, W. Sittitrai,, T. J. John,, and T. Kitamura. 1994. The emerging epidemic of HIV infection and AIDS in Asia and the Pacific. AIDS 8(Suppl. 2):S165S172.
48. Kalichman, S. C.,, J. A. Kelly,, K. J. Sikkema,, A. P. Koslov,, A. Shaboltas,, and J. Granskaya. 2000. The emerging AIDS crisis in Russia: review of enabling factors and prevention needs. Int. J. STD AIDS 11:7175.
49. Kanki, P. 1991. Biologic features of HIV-2. An update. AIDS Clin. Rev. 1991:1738.
50. Kanki, P. J.,, F. Barin,, S. M'Boup,, J. S. Allan,, J. L. Romet-Lemonne,, R. Marlink,, M. F. McLane,, T. H. Lee,, B. Arbeille,, and F. Denis. 1986. New human T-lymphotropic retrovirus related to simian Tlymphotropic virus type III (STLV-IIIAGM). Science 232:238243.
51. Kanki, P. J.,, and K. M. DeCock. 1994. Epidemiology and natural history of HIV-2. AIDS 8(Suppl. 1):S85.
52. Kanki, P.,, S. M'Boup,, R. Marlink,, K. Travers,, C. C. Hsieh,, A. Gueye,, C. Boye,, J. L. Sankale,, C. Donnelly,, and W. Leisenring. 1992. Prevalence and risk determinants of human immunodeficiency virus type 2 (HIV-2) and human immunodeficiency virus type 1 (HIV-1) in west African female prostitutes. Am. J. Epidemiol. 136:895907.
53. Kanki, P. J.,, K. U. Travers,, S. M'Boup,, C. C. Hsieh,, R. G. Marlink,, A. Gueye-NDiaye,, T. Siby,, I. Thior,, M. Hernandez-Avila,, and J. L. Sankale. 1994. Slower heterosexual spread of HIV-2 than HIV-1. Lancet 343:943946.
54. Kato, K.,, T. Shiino,, S. Kusagawa,, H. Sato,, S. Nohtomi,, K. Shibamura,, T. H. Nguyen,, K. C. Pham,, X. L. Truong,, H. A. Mai,, T. L. Hoang,, G. Bunyaraksyotin,, Y. Fukushima,, M. Honda,, C. Wasi,, S. Yamazaki,, Y. Nagai,, and Y. Takebe. 1999. Genetic similarity of HIV type 1 subtype E in a recent outbreak among injecting drug users in northern Vietnam to strains in Guangxi Province of southern China. AIDS Res. Hum. Retrovir. 15:11571168.
55. Katz, M. H.,, S. K. Schwarcz,, T. A. Kellogg,, J. D. Klausner,, J. W. Dilley,, S. Gibson,, and W. McFarland. 2002. Impact of highly active antiretroviral treatment on HIV seroincidence among men who have sex with men: San Francisco. Am. J. Public Health 92:388394.
56. Kitayaporn, D.,, C. Uneklabh,, B. G. Weniger,, P. Lohsomboon,, J. Kaewkungwal,, W. M. Morgan,, and T. Uneklabh. 1994. HIV-1 incidence determined retrospectively among drug users in Bangkok, Thailand. AIDS 8:14431450.
57. Korber, B.,, M. Muldoon,, J. Theiler,, F. Gao,, R. Gupta,, A. Lapedes,, B. H. Hahn,, S. Wolinsky,, and T. Bhattacharya. 2000. Timing the ancestor of the HIV-1 pandemic strains. Science 288:17861789.
58. Kunanusont, C.,, H. M. Foy,, J. K. Kreiss,, S. Rerks-Ngarm,, P. Phanuphak,, S. Raktham,, C. P. Pau,, and N. L. Young. 1995. HIV-1 subtypes and male-to-female transmission in Thailand. Lancet 345:10781083.
59. Laga, M.,, K. M. De Cock,, N. Kaleeba,, S. M'boup,, and D. Tarantola. 1997. HIV/AIDS in Africa: the second decade and beyond. AIDS 11(Suppl. B):S1S3.
60. Laurent, C.,, A. Bourgeois,, M. A. Faye,, R. Mougnutou,, M. Seydi,, M. Gueye,, F. Liegeois,, C. T. Kane,, C. Butel,, J. Mbuagbaw,, L. Zekeng,, S. M'boup,, E. Mpoudi-Ngole,, M. Peeters,, and E. Delaporte. 2002. No difference in clinical progression between patients infected with the predominant human immunodeficiency virus type 1 circulating recombinant form (CRF) 02_AG strain and patients not infected with CRF02_AG, in western and west-central Africa: a four-year prospective multicenter study. J. Infect. Dis. 186:486492.
61. Louwagie, J.,, E. L. Delwart,, J. L. Mullins,, F. E. McCutchan,, G. Eddy,, and D. S. Burke. 1994. Genetic analysis of HIV-1 isolates from Brazil reveals presence of two distinct genetic subtypes. AIDS Res. Hum. Retrovir. 10:561567.
62. Lowndes, C. M.,, M. Alary,, and L. Platt. 2003. Injection drug use, commercial sex work, and the HIV/STI epidemic in the Russian Federation. Sex. Transm. Dis. 30:4648.
63. Mamadou, S.,, C. Montavon,, A. Ben,, A. Djibo,, S. Rabiou,, S. M'boup,, E. Delaporte,, and M. Peeters. 2002. Predominance of CRF02-AG and CRF06-cpx in Niger, West Africa. AIDS Res. Hum. Retrovir. 18:723726.
64. Mann, J. M.,, J. Chin,, P. Piot,, and T. C. Quinn. 1988. The international epidemiology of AIDS. Sci. Am. 259:8289.
65. Markovitz, D. M. 1993. Infection with the human immunodeficiency virus type 2. Ann. Intern. Med. 118:211218.
66. Marlink, R., 1994. Biology and epidemiology of HIV-2, p. 4765. In M. Essex,, M. Kalengay,, and P. Kanki (ed.), AIDS in Africa. Raven Press, New York, N.Y.
67. Masur, H.,, M. A. Michelis,, J. B. Greene,, I. Onorato,, R. A. Stouwe,, R. S. Holzman,, G. Wormser,, L. Brettman,, M. Lange,, H. W. Murray,, and S. Cunningham-Rundles. 1981. An outbreak of communityacquired Pneumocystis carinii pneumonia: initial manifestation of cellular immune dysfunction. N. Engl. J. Med. 305:14311438.
68. Mbulaiteye, S. M.,, C. Mahe,, J. A. Whitworth,, A. Ruberantwari,, J. S. Nakiyingi,, A. Ojwiya,, and I. Kamal. 2002. Declining HIV-1 incidence and associated prevalence over 10 years in a rural population in south-west Uganda: a cohort study. Lancet 360:4146.
69. McCutchan, F. E. 2000. Understanding the genetic diversity of HIV-1. AIDS 14(Suppl. 3):S31S44.
70. McCutchan, F. E.,, M. O. Salminen,, J. K. Carr,, and D. S. Burke. 1996. HIV-1 genetic diversity. AIDS 10(Suppl. 3):S13S20.
71. Mehendale, S. M.,, J. J. Rodrigues,, R. S. Brookmeyer,, R. R. Gangakhedkar,, A. D. Divekar,, M. R. Gokhale,, A. R. Risbud,, R. S. Paranjape,, M. E. Shepherd,, and A. E. Rompalo. 1995. Incidence and predictors of human immunodeficiency virus type 1 seroconversion in patients attending sexually transmitted diseases clinics in India. J. Infect. Dis. 172:14861491.
72. Miotti, P. G.,, G. Dallabetta,, E. Ndovi,, G. Liomba,, A. J. Saah,, and J. Chiphangwi. 1990. HIV-1 and pregnant women: associated factors, prevalence, estimate of incidence and role in fetal wastage in central Africa. AIDS 4:733736.
73. Montavon, C.,, C. Toure-Kane,, J. N. Nkengagsong,, L. Vergne,, K. Hertogs,, S. M'boup,, E. Delaporte,, and M. Peeters. 2002. CRF06-cpx: a new circulating recombinant form of HIV-1 in West Africa involving subtypes A, G, K, and J. J. Acquir. Immune Defic. Syndr. 29:522530.
74. Morgado, M. G.,, E. C. Sabino,, E. G. Shpaer,, V. Bongertz,, L. Brigido,, M. D. Guimaraes,, E. A. Castilho,, B. Galvao-Castro,, J. L. Mullins,, and R. M. Hendry. 1994. V3 region polymorphisms in HIV- 1 from Brazil: prevalence of subtype B strains divergent from North American/European prototype and detection of subtype F. AIDS Res. Hum. Retrovir. 10:569576.
75. Morison, L. 2001. The global epidemiology of HIV/AIDS. Br. Med. Bull. 58:718.
76. Morison, L.,, A. Buve,, L. Zekeng,, L. Heyndrickx,, S. Anagonous,, R. Musonda,, M. Kahindo,, H. A. Weiss,, R. J. Hayes,, M. Laga,, W. Janssens,, and G. van der Groen. 2001. HIV-1 subtypes and the HIV epidemics in four cities in sub-Saharan Africa. AIDS 15(Suppl. 4):S109S116.
77. Muller-Trutwin, M. C.,, S. Corbet,, S. Souquiere,, P. Roques,, P. Versmisse,, A. Ayouba,, S. Delarue,, E. Nerrienet,, J. Lewis,, P. Martin,, F. Simon,, F. Barre-Sinoussi,, and P. Mauclere. 2000. SIVcpz from a naturally infected Cameroonian chimpanzee: biological and genetic comparison for HIV-1 N. J. Med. Primatol. 29:166172.
78. Myers, G. 1994. HIV: between past and future. AIDS Res. Hum. Retrovir. 10:13171324.
79. Nabatov, A. A.,, O. N. Kavchenko,, M. G. Lyulchuk,, A. M. Shcherbinskaya, and V. V. Lukashov. 2002. Simultaneous introduction of HIV type 1 subtype A and B viruses into injecting drug users in southern Ukraine at the beginning of the epidemic in the former Soviet Union. AIDS Res. Hum. Retrovir. 18:891895.
80. Naganawa, S.,, S. Sato,, D. Nossik,, K. Takahashi,, T. Hara,, O. Tochikubo,, K. Kitamura,, M. Honda,, and T. Nakasone. 2002. First report of CRF03_AB recombinant HIV type 1 in injecting drug users in Ukraine. AIDS Res. Hum. Retrovir. 18:11451149.
81. Nelson, K. E.,, D. D. Celentano,, S. Supraset,, N. Wright,, S. Eiumtrakul,, S. Tulvatana,, A. Matanasarawoot,, P. Akarasewi,, S. Kuntolbutra,, and S. Romyen. 1993. Risk factors for HIV infection among young adult men in northern Thailand. JAMA 270:955960.
82. Nzilambi, N.,, K. M. De Cock,, D. N. Forthal,, H. Francis,, R. W. Ryder,, I. Malebe,, J. Getchell,, M. Laga,, P. Piot,, and J. B. McCormick. 1988. The prevalence of infection with human immunodeficiency virus over a 10-year period in rural Zaire. N. Engl. J. Med. 318:276279.
83. Osmanov, S.,, C. Pattou,, N. Walker,, B. Schwardlander,, and J. Esparza. 2002. Estimated global distribution and regional spread of HIV-1 genetic subtypes in the year 2000. J. Acquir. Immune Defic. Syndr. 29:184190.
84. Papa, A.,, E. Papadimitrious,, A. Papoutsi,, V. Kiosses,, and A. Antoniadis. 2002. HIV-1 subtypes and circulating recombinant forms (CRFs) in northern Greece. Virus Res. 85:8593.
85. Pape, J.,, and W. D. Johnson, Jr. 1993. AIDS in Haiti: 1982–1992. Clin. Infect. Dis. 17(Suppl. 2): S341S345.
86. Pape, J. W.,, B. Liautaud,, F. Thomas,, J. R. Mathurin,, M. M. St. Amand,, M. Boncy,, V. Pean,, M. Pamphile,, A. C. Laroche,, and W. D. Johnson, Jr. 1983. Characteristics of the acquired immunodeficiency syndrome (AIDS) in Haiti. N. Engl. J. Med. 309:945950.
87. Perrin, L.,, L. Kaiser,, and S. Yerley. 2003. Travel and the spread of HIV-1 genetic variants. Lancet Infect. Dis. 3:2227.
88. Pieniazek, D.,, L. M. Janini,, A. Ramos,, A. Tanuri,, M. Schechter,, J. M. Peralta,, A. C. Vicente,, N. K. Pieniazek,, G. Schochetman,, and M. A. Rayfield. 1995. HIV-patients may harbor viruses of different phylogenetic subtypes: implications for the evolution of the HIV/AIDS pandemic. Emerg. Infect. Dis. 1:8688.
89. Piot, P.,, M. Bartos,, P. D. Ghys,, N. Walker,, and B. Schwartlander. 2001. The global impact of HIV/AIDS. Nature 410:968973.
90. Piot, P.,, J. Goeman,, and M. Laga,. 1994. The epidemiology of HIV and AIDS in Africa, p. 157172. In M. Essex,, S. Mboup,, P. Kanki,, and M. Kalengayi (ed.), AIDS in Africa. Raven Press, New York, N.Y.
91. Piot, P.,, F. A. Plummer,, F. S. Mhlau,, J. L. Lamboray,, J. Chin,, and J. M. Mann. 1988. AIDS: an international perspective. Science 239:573579.
92. Piot, P.,, T. C. Quinn,, H. Taelman,, F. M. Feinsod,, K. B. Minlangu,, O. Wobin,, N. Mbendi,, P. Mazebo,, K. Ndangi,, and W. Stevens. 1984. Acquired immunodeficiency syndrome in a heterosexual population in Zaire. Lancet 2:6569.
93. Preble, E. A. 1990. Impact of HIV/AIDS on African children. Soc. Sci. Med. 31:671680.
94. Quinn, T. C. 1996. Global burden of the HIV pandemic. Lancet 348:99106.
95. Quinn, T. C. 1994. Population migration and the spread of types 1 and 2 human immunodeficiency viruses. Proc. Natl. Acad. Sci. USA 91:24072414.
96. Quinn, T. C.,, J. M. Mann,, J. W. Curran,, and P. Piot. 1986. AIDS in Africa: an epidemiologic paradigm. Science 234:955963.
97. Quinn, T. C.,, M. J. Wawer,, N. Sewankambo,, D. Serwadda,, C. Li,, F. Wabwire-Mangen,, M. O. Meehan,, T. Lutalo,, and R. H. Gray. 2000. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N. Engl. J. Med. 342:921929.
98. Reynolds, S. J.,, J. G. Bartlett,, T. C. Quinn,, C. Beyrer,, and R. C. Bollinger. 2003. Anti-retroviral therapy where resources are limited. N. Engl. J. Med. 348:18061808.
99. Rodrigues, J. J.,, S. M. Mehendale,, M. E. Shepherd,, A. D. Divekar,, R. R. Gangakhedkar,, T. C. Quinn,, R. S. Paranjape,, A. R. Risbud,, R. S. Brookmeyer,, and D. A. Gadkari. 1995. Risk factors for HIV infection in people attending clinics for sexually transmitted diseases in India. BMJ 311:283286.
100. Rodriguez, C. M.,, L. F. Marques,, and G. Touze. 2002. HIV and injection drug use in Latin America. AIDS 16(Suppl. 3):S34S41.
101. Schlaegenhauf, P.,, and H. Ashraf. 2003. HIV/AIDS lowers UN's global population estimates. Lancet 361:841.
102. Sewankambo, N. K.,, M. J. Wawer,, R. H. Gray,, D. Serwadda,, C. Li,, R. Y. Stallings,, S. D. Musgrave,, and J. Konde-Lule. 1994. Demographic impact of HIV infection in rural Rakai district, Uganda: results of a population-based cohort study. AIDS 8:17071713.
103. Siegal, F. P.,, C. Lopez,, G. S. Hammer,, A. E. Brown,, S. J. Kornfeld,, J. Gold,, J. Hassett,, S. Z. Hirschman,, C. Cunningham-Rundles,, and B. R. Adelsberg. 1981. Severe acquired immunodeficiency in male homosexuals, manifested by chronic perianal ulcerative herpes simplex lesions. N. Engl. J. Med. 305:14391444.
104. St. Louis, M.,, M. Kamenga,, C. Brown,, A. M. Nelson,, T. Manzila,, V. Batter,, F. Behets,, U. Kabagabo,, R. W. Ryder,, and M. Oxtoby. 1993. Risk for perinatal HIV-1 transmission according to maternal immunologic, virologic, and placental factors. JAMA 269:28532859.
105. Stover, J.,, N. Walker,, G. P. Garentt,, J. A. Salomon,, K. Staneck,, P. D. Ghys,, N. C. Grassly,, R. M. Anderson,, and B. Schwartlander. 2002. Can we reverse the HIV/AIDS pandemic with an expanded response? Lancet 360:7377.
106. Tatt, I. D.,, K. L. Barlow,, A. Nicoll,, and J. P. Clewley. 2001. The public health significance of HIV-1 subtypes. AIDS 15(Suppl. 5):S59S71.
107. Tebit, D. M.,, L. Zekeng,, L. Kaptue,, M. Salminen,, H. G. Krausslich,, and O. Herchenroder. 2002. Genotypic and phenotypic anaysis of HIV type 1 primary isolates from western Cameroon. AIDS Res. Hum. Retrovir. 18:3948.
108. Thomson, M. M.,, and R. Najera. 2001. Travel and the introduction of human immunodeficiency virus type 1 non-B subtype genetic forms into western countries. Clin. Infect. Dis. 32:17321737.
109. Thomson, M. M.,, L. Perez-Alvarez,, and R. Najera. 2002. Molecular epidemiology of HIV-1 genetic forms and its significance for vaccine development and therapy. Lancet Infect. Dis. 2:461471.
110. Travers, K.,, S. M'boup,, R. Marlink,, A. Gueye-Nidaye,, T. Siby,, I. Thior,, I. Traore,, A. Dieng-Sarr,, J. L. Sankale,, and C. Mullins. 1995. Natural protection against HIV-1 infection provided by HIV-2. Science 268:16121615.
111. UNAIDS/WHO. 2002. Report on the Global HIV/AIDS Epidemic, 2002, p. 1226. UNAIDS and WHO, Geneva, Switzerland.
112. UNAIDS/WHO. 2002. AIDS Epidemic Update, December 2002, p. 138. UNAIDS and WHO, Geneva, Switzerland.
113. U.S. Bureau of the Census. 1994. Trends and Patterns of HIV and AIDS Infection in Selected Developing Countries: Country Profiles: June 1994. Research Note 14. U.S. Bureau of the Census, Washington, D.C.
114. Viputtijul, K.,, M. de Souza,, R. Trichavaroj,, J. K. Carr,, S. Tovanabutra,, F. E. McCutchan,, S. Sriplienchan,, P. Buapumth,, C. Chuenchitra,, J. G. McNeil,, D. L. Birx,, A. E. Brown,, and S. Nitayaphan. 2002. Heterosexually acquired CRF01_AE/B recombinant HIV type 1 found in Thailand. AIDS Res. Hum. Retrovir. 18:12351237.
115. Vu, M. Q.,, R. W. Steketee,, L. Valleroy,, H. Weinstock,, J. Karon,, and R. Janssen. 2002. HIV incidence in the United States, 1978–1999. J. Acquir. Immune Defic. Syndr. 31:188201.
116. Wawer, M.,, N. Sewankambo,, S. Berkley,, D. Serwadda,, S. D. Musgrave,, R. H. Gray,, M. Musagara,, R. Y. Stallings,, and J. K. Konde-Lule. 1994. HIV incidence in a rural district of Uganda. BMJ 308:171173.
117. Weidle, P. J.,, T. D. Mastro,, A. D. Grant,, J. Nkengasong,, and D. Macharia. 2002. HIV/AIDS treatment and HIV vaccines for Africa. Lancet 359:22612267.
118. Weniger, B. G.,, K. Limpakarnjanarat,, K. Ungchusak,, S. Thanprasertsuk,, K. Choopanya,, S. Vanichseni,, T. Uneklabh,, P. Thongcharoen,, and C. Wasi. 1991. The epidemiology of HIV infection and AIDS in Thailand. AIDS 5(Suppl. 2):S71S85.
119. Weniger, B. G.,, Y. Takebe,, C.-Y. Ou,, and S. Yamazaki. 1994. The molecular epidemiology of HIV in Asia. AIDS 8(Suppl. 2):S13S28.
120. Working Group on Mother-to-Child Transmission of HIV. 1995. Rates of mother-to-child transmission of HIV-1 in Africa, America, and Europe: results from 13 perinatal studies. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 8:506510.
121. Xia, M.,, J. K. Kreiss,, and K. K. Holmes. 1994. Risk factors for HIV infection among drug users in Yunnan Province, China: association with intravenous drug use and protective effect of boiling reusable needles and syringes. AIDS 8:17011706.
122. Yu, X. F.,, J. Chen,, Y. Shao,, C. Beyrer,, B. Liu,, Z. Wang,, W. Liu,, J. Yang,, S. Liang,, R. P. Viscidi,, J. Gu,, G. Gurri-Glass,, and S. Lai. 1999. Emerging HIV infections with distinct subtypes of HIV-1 infection among injection drug users from geographically separate locations in Guangxi Province, China. J. Acquir. Immun. Defic. Syndr. 22:180188.
123. Yu, X. F.,, W. Liu,, J. Chen,, W. Kong,, B. Liu,, Q. Zhu,, F. Liang,, F. McCutchan,, S. Piyasirisilp,, and S. Lai. 2002. Maintaining low HIV type 1 env genetic diversity among injection drug users infected with a B/C recombinant and CRF01_AE HIV type 1 in southern China. AIDS Res. Hum. Retrovir. 18:167170.


Generic image for table
Table 1

Global summary of the HIV/AIDS epidemic, December 2002

Citation: Quinn T. 2004. The Global Epidemiology of AIDS, p 59-82. In Scheld W, Murray B, Hughes J (ed), Emerging Infections 6. ASM Press, Washington, DC. doi: 10.1128/9781555816995.ch5
Generic image for table
Table 2

Regional HIV/AIDS statistics and features at the end of 2002

Citation: Quinn T. 2004. The Global Epidemiology of AIDS, p 59-82. In Scheld W, Murray B, Hughes J (ed), Emerging Infections 6. ASM Press, Washington, DC. doi: 10.1128/9781555816995.ch5

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error